MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma
Open Access
- 19 July 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 495
Abstract
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated epithelial malignancy that exhibits distinct geographical and ethnic prevalence. Although the contemporary therapeutic approach of radio-/chemotherapy provides excellent results for patients with early-stage disease, it is far from satisfactory for those with disease remission and distant metastasis. Promising therapeutic strategies for advanced and relapsed NPC are still lacking. We recently identified and characterized a cancer stem-like cell (CSC) subpopulation in NPC that appeared to play an important role in tumor progression. Microarray analysis revealed downregulation of several stemness-inhibiting miRNAs in these CSC cells. Among these miRNAs, miR-96 and miR-183 showed the highest fold change and were selected to elucidate their role in repressing NPC CSC properties. MiR-96 and miR-183 expression in NPC CSCs was detected by qRT-PCR. Transient and stable transfection was performed in EBV-positive NPC C666-1 cells to examine the effects of ectopic expression of miR-96 and miR-183 on repressing cell growth and CSC properties. Anchorage-dependent (colony formation) and anchorage-independent (tumor sphere formation) growths of these miR-96 and miR-183 expressing cells were determined. Expression of multiple CSC markers and related molecules were accessed by flow cytometry and Western blotting. The tumorigenicity of the stable miR-96- and miR-183-transfected NPC cells was examined in an in vivo nude mice model. Downregulation of miR-96 and miR-183 was confirmed in NPC spheroids. Using transient or stable transfection, we showed that ectopic expression of miR-96 and miR-183 suppressed cell growth and tumor sphere formation in NPC. Reduced NICD3 and NICD4 in miR-96- and miR-183-expressing NPC cells suggests the involvement of the NOTCH signaling pathway in their tumor suppressive function. Finally, we showed that the tumorigenicity of cells stably expressing miR-183 was significantly inhibited in the in vivo nude mice model. miR-183 is a tumor-suppressive miRNA in EBV-associated NPC. Its abilities to suppress CSC properties in vitro and effectively reduce tumor growth in vivo shed light on its role as a potential therapeutic target.Keywords
Funding Information
- Research Grants Council, University Grants Committee, Hong Kong (HK) (GRF (470413, 470312,471211), CRF (CUHK8/CRF/11R))
- Research Grants Council, University Grants Committee, Hong Kong (HK) (Area of Excellence NPC (AoE/M-06/08))
- Research Grants Council, University Grants Committee, Hong Kong (HK) (Theme-based research scheme (T12-403/11, T12-401/13-R))
- The Chinese University of Hong Kong (Focus Investigation Scheme-A, Vice-Chancellor’s One-off Discretionary Fund)
This publication has 35 references indexed in Scilit:
- MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT SignalingMolecular Cancer Therapeutics, 2015
- Cancer stem cells, cancer cell plasticity and radiation therapySeminars in Cancer Biology, 2015
- Five miRNAs as Novel Diagnostic Biomarker Candidates for Primary Nasopharyngeal CarcinomaAsian Pacific Journal of Cancer Prevention, 2014
- miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancerInternational Journal of Molecular Medicine, 2014
- Cancer stem cells – important players in tumor therapy resistanceThe FEBS Journal, 2014
- A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian CancerPLOS ONE, 2014
- Down-Regulation of miR-183 Promotes Migration and Invasion of Osteosarcoma by Targeting EzrinThe American Journal of Pathology, 2012
- MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cellsMolecular Medicine Reports, 2012
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAsNature Cell Biology, 2009
- Clonogenic assay of cells in vitroNature Protocols, 2006